{
    "2021-07-22": [
        [
            {
                "time": "2021-08-15",
                "original_text": "Best REIT Dividend Stocks According to Hedge Funds",
                "features": {
                    "keywords": [
                        "REIT",
                        "Dividend",
                        "Hedge Funds"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "real estate"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-08-16",
                "original_text": "10 REIT Dividend Stocks with Over 5% Yields",
                "features": {
                    "keywords": [
                        "REIT",
                        "Dividend",
                        "Yields"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "real estate"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-07-14",
                "original_text": "Healthcare ETFs in Focus as Q2 Earnings Unfold",
                "features": {
                    "keywords": [
                        "Healthcare",
                        "ETFs",
                        "Q2 Earnings"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-04",
                "original_text": "Roche's (RHHBY) 1H21 Sales Rise Despite Impact of Biosimilars",
                "features": {
                    "keywords": [
                        "Roche",
                        "Sales",
                        "Biosimilars"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-09-01",
                "original_text": "Pfizer (PFE) Inks Vaccine Deal, Faces FDA Delay on JAK Drugs",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Vaccine",
                        "FDA",
                        "JAK Drugs"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "mixed",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-07-22",
                "original_text": "Rebound In COVID-19 Tests Lift Roche's Half-Year Sales, Oncology Still Hit By Biosimilars, Pandemic",
                "features": {
                    "keywords": [
                        "Roche",
                        "COVID-19",
                        "Tests",
                        "Oncology",
                        "Biosimilars"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-06-10",
                "original_text": "3 Biotechs That Could Make Big Acquisitions This Year",
                "features": {
                    "keywords": [
                        "Biotechs",
                        "Acquisitions"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}